| Pharmaceutical applications of hot-melt extrusion: part I MM Crowley, F Zhang, MA Repka, S Thumma, SB Upadhye, ... Drug development and industrial pharmacy 33 (9), 909-926, 2007 | 1053 | 2007 |
| Hot-melt extrusion: from theory to application in pharmaceutical formulation H Patil, RV Tiwari, MA Repka Aaps Pharmscitech 17, 20-42, 2016 | 616 | 2016 |
| Pharmaceutical applications of hot-melt extrusion: Part II MA Repka, SK Battu, SB Upadhye, S Thumma, MM Crowley, F Zhang, ... Drug development and industrial pharmacy 33 (10), 1043-1057, 2007 | 578 | 2007 |
| Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets J Zhang, X Feng, H Patil, RV Tiwari, MA Repka International journal of pharmaceutics 519 (1-2), 186-197, 2017 | 431 | 2017 |
| Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof MA Repka, SL Repka, JW McGinity US Patent 6,375,963, 2002 | 334 | 2002 |
| Applications of hot-melt extrusion for drug delivery MA Repka, S Majumdar, S Kumar Battu, R Srirangam, SB Upadhye Expert opinion on drug delivery 5 (12), 1357-1376, 2008 | 310 | 2008 |
| Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion MA Repka, TG Gerding, SL Repka, JW McGinity Drug development and industrial pharmacy 25 (5), 625-633, 1999 | 306 | 1999 |
| Melt extrusion with poorly soluble drugs S Shah, S Maddineni, J Lu, MA Repka International journal of pharmaceutics 453 (1), 233-252, 2013 | 287 | 2013 |
| Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants SK Battu, MA Repka, S Majumdar, M Rao Y Drug development and industrial pharmacy 33 (11), 1225-1232, 2007 | 249 | 2007 |
| Melt extrusion with poorly soluble drugs–An integrated review MA Repka, S Bandari, VR Kallakunta, AQ Vo, H McFall, MB Pimparade, ... International journal of pharmaceutics 535 (1-2), 68-85, 2018 | 234 | 2018 |
| Characterization of cellulosic hot-melt extruded films containing lidocaine MA Repka, K Gutta, S Prodduturi, M Munjal, SP Stodghill European Journal of Pharmaceutics and Biopharmaceutics 59 (1), 189-196, 2005 | 233 | 2005 |
| Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation J Zhang, W Yang, AQ Vo, X Feng, X Ye, DW Kim, MA Repka Carbohydrate polymers 177, 49-57, 2017 | 222 | 2017 |
| Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery SK Battu, MA Repka, S Maddineni, AG Chittiboyina, MA Avery, ... Aaps Pharmscitech 11, 1466-1475, 2010 | 215 | 2010 |
| Melt extrusion: process to product MA Repka, S Shah, J Lu, S Maddineni, J Morott, K Patwardhan, ... Expert opinion on drug delivery 9 (1), 105-125, 2012 | 193 | 2012 |
| Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion MA Repka, JW McGinity Journal of Controlled Release 70 (3), 341-351, 2001 | 179 | 2001 |
| Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century RV Tiwari, H Patil, MA Repka Expert opinion on drug delivery 13 (3), 451-464, 2016 | 176 | 2016 |
| Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion MA Repka, JW McGinity International journal of pharmaceutics 202 (1-2), 63-70, 2000 | 175 | 2000 |
| The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films MM Crowley, A Fredersdorf, B Schroeder, S Kucera, S Prodduturi, ... European Journal of Pharmaceutical Sciences 22 (5), 409-418, 2004 | 165 | 2004 |
| 3D-printed isoniazid tablets for the treatment and prevention of tuberculosis—personalized dosing and drug release H Öblom, J Zhang, M Pimparade, I Speer, M Preis, M Repka, N Sandler Aaps Pharmscitech 20, 1-13, 2019 | 152 | 2019 |
| Production and characterization of hot-melt extruded films containing clotrimazole MA Repka, S Prodduturi, SP Stodghill Drug development and industrial pharmacy 29 (7), 757-765, 2003 | 152 | 2003 |
